1. 河南中医药大学老年医学研究所
2. 呼吸疾病诊疗与新药研发河南省协同创新中心
3. 河南中医药大学第一附属医院
4. 河南省人民医院
5. 河南省胸科医院
6. 浙江中医药大学附属第二医院
纸质出版:2017
移动端阅览
[1]李建生,张海龙,王海峰,曹帆,侯聪霞,潘颖超,张盼奎,余学庆.慢性阻塞性肺疾病证候演变特点临床调查[J].中医杂志,2017,58(09):772-776.
LI Jiansheng, ZHANG Hailong, WANG Haifeng, et al. Clinical Survey on Syndrome Evolution Characteristics in Chronic Obstructive Pulmonary Disease Patients[J]. Journal of Traditional Chinese Medicine2017, 58(9): 772-776.
[1]李建生,张海龙,王海峰,曹帆,侯聪霞,潘颖超,张盼奎,余学庆.慢性阻塞性肺疾病证候演变特点临床调查[J].中医杂志,2017,58(09):772-776. DOI: 10.13288/j.11-2166/r.2017.09.014.
LI Jiansheng, ZHANG Hailong, WANG Haifeng, et al. Clinical Survey on Syndrome Evolution Characteristics in Chronic Obstructive Pulmonary Disease Patients[J]. Journal of Traditional Chinese Medicine2017, 58(9): 772-776. DOI: 10.13288/j.11-2166/r.2017.09.014.
目的探讨慢性阻塞性肺疾病(COPD)急性加重期-危险窗-稳定期中医证候演变特点。方法收集8家医院COPD急性加重期、危险窗、稳定期患者500例
制定AECOPD危险窗中医证候临床研究调查表
调查内容包括患者一般人口学资料、疾病相关指标和中医四诊信息指标
分别观察并记录COPD急性加重期、危险窗及稳定期各阶段基础证、临床证候的分布及演变情况。结果收回急性加重期、危险窗期有效调查表各406份
稳定期有效调查表370份。病性:COPD在急性加重期
病性虚实比为1∶2.86
证候以实为主;危险窗时
病性虚实比为1∶1.06
证候以虚实夹杂为主;稳定期
病性虚实比为1∶0.09
证候以虚为主。病位:痰热壅肺、痰湿阻肺、外寒内饮、痰热壅肺兼肺肾气虚、痰热壅肺兼血瘀和痰湿阻肺兼肺脾气虚为急性加重期的6个主要证候
急性加重期病位以肺为主
进入危险窗后新增病位心和脾
进入稳定期后
病位以肺肾和肺脾多见。急性加重期共出现54种证候类型
危险窗期53种
稳定期44种。结论COPD急性加重期以实证为主
病位主要在肺;危险窗虚实兼半
病位在肺、脾及肾;稳定期以虚证为主
病位在肺、脾及肾
体现了本病本虚标实的临床特点。
Objective To explore the Chinese medicine syndrome evolution characteristics of acute exacerbationrisk window-stationary phase of chronic obstructive pulmonary disease( COPD). Methods Totally 500 COPD patients( acute exacerbation
risk window and stationary phase) from 8 hospitals were collected. Chinese medicine syndrome clinical research questionnaires of acute exacerbation of COPD( AECOPD) and risk window were made.The survey included patients’ general demographic data
disease related indexes and Chinese medicine four diagnostic information indexes. The basic syndrome
distribution of clinical syndrome and the evolution in COPD acute exacerbation
risk window and stationary phase were examined and recorded. Results Questionnaires in acute exacerbation and risk window recalled were both 406. Questionnaires in stationary phase were 370. 1) Nature of disease. In acute exacerbation of COPD
deficiency-excess ratio of disease nature was 1 ∶ 2. 86. The main syndrome was excess. In risk window
the ratio was 1 ∶ 1. 06. The main syndrome was intermingled deficiency and excess. In stationary phase
the ratio was 1 ∶ 0. 09. The main syndrome was deficiency. 2) Location of disease. Six main syndromes in acute exacerbation were phlegm-heat obstructing lung
phlegm-damp obstructing lung
external cold and internal fluid
phlegm-heat obstructing lung with Qi deficiency of lung and kidney
phlegm-heat obstructing lung with blood stasis
as well as phlegm-damp obstructing lung with Qi deficiency of lung and spleen. In acute exacerbation
the location of disease was mainly lung. After going to risk window
new disease location heart and spleen increased.After going to stationary phase
common disease locations were lung-kidney and lung-spleen. In acute exacerbation
there were 54 syndromes recorded
53 in risk window
and 44 in stationary phase. Conclusion In acute exacerbation of COPD
the main syndrome was excess syndrome; the main disease location was lung. In risk window
the syndrome was intermingled deficiency and excess; the disease locations were lung
spleen and kidney. In stationary phase
the main syndrome was deficiency syndrome; the disease locations were lung
spleen and kidney. The results reflected the clinical characteristics of asthenia in origin and asthenia in superficiality of this disease.
0
浏览量
808
下载量
13
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号